Penggunaan Obat Antivirus Bagi Penderita COVID – 19 di RS Universitas Udayana Tahun 2022 – 2023 Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.36418/syntax-literate.v9i12.55251
COVID-19, yang disebabkan oleh virus SARS-CoV-2, pertama kali ditemukan di Wuhan, Cina, dan menjadi ancaman kesehatan global sejak awal 2020. Penelitian mengenai penggunaan obat antivirus di RS Universitas Udayana pada 2022-2023 penting untuk memberikan gambaran lengkap tentang terapi COVID-19. Penelitian ini dilakukan untuk mengetahui penggunaan obat antivirus pada penderita COVID – 19 di RS Universitas Udayana pada tahun 2022 – 2023 Penelitian ini merupakan penelitian deskriptif dengan pendekatan potong lintang (cross – sectional) untuk mengetahui gambaran penggunaan obat antivirus bagi penderita COVID – 19 di RS Universitas Udayana pada tahun 2022 - 2023. Data dikumpulkan secara retrospektif dengan melihat rekam medis pasien COVID – 19 pada tahun 2022 - 2023 di RS Universitas Udayana setelah mendapatkan izin dari pihak – pihak yang bersangkutan. Kemudian data diolah dengan software IBM SPSS 26. Hasil penelitian menunjukan dari total 101 pasien COVID-19, mayoritas adalah laki-laki dengan persentase 50,5%, dan kelompok usia 19-35 tahun merupakan yang paling banyak terpapar; sekitar 63,4% pasien memiliki komorbid, dan mayoritas pasien mengalami derajat keparahan rendah (73,3%); dalam penanganan, Favipiravir adalah obat antivirus yang paling sering digunakan. Dari total 101 pasien COVID-19, laki-laki lebih dominan dan kelompok usia dewasa muda hingga paruh baya, terutama 19-35 tahun, adalah yang paling banyak terinfeksi. Sebagian besar pasien memiliki komorbid, yang memperburuk kondisi mereka. Meskipun mayoritas pasien mengalami derajat keparahan rendah, Favipiravir merupakan obat antivirus utama yang digunakan dalam terapi,
Related Topics
- Type
- article
- Language
- id
- Landing Page
- https://doi.org/10.36418/syntax-literate.v9i12.55251
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4405769179
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4405769179Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.36418/syntax-literate.v9i12.55251Digital Object Identifier
- Title
-
Penggunaan Obat Antivirus Bagi Penderita COVID – 19 di RS Universitas Udayana Tahun 2022 – 2023Work title
- Type
-
articleOpenAlex work type
- Language
-
idPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-25Full publication date if available
- Authors
-
Kadek Agastya Widya Sedana Grudug, I Made Jawi, I Gusti Ayu ArtiniList of authors in order
- Landing page
-
https://doi.org/10.36418/syntax-literate.v9i12.55251Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.36418/syntax-literate.v9i12.55251Direct OA link when available
- Concepts
-
Medicine, Gynecology, Humanities, ArtTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4405769179 |
|---|---|
| doi | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| ids.doi | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| ids.openalex | https://openalex.org/W4405769179 |
| fwci | 0.0 |
| type | article |
| title | Penggunaan Obat Antivirus Bagi Penderita COVID – 19 di RS Universitas Udayana Tahun 2022 – 2023 |
| biblio.issue | 12 |
| biblio.volume | 9 |
| biblio.last_page | 7623 |
| biblio.first_page | 7613 |
| topics[0].id | https://openalex.org/T13032 |
| topics[0].field.id | https://openalex.org/fields/33 |
| topics[0].field.display_name | Social Sciences |
| topics[0].score | 0.9833999872207642 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3312 |
| topics[0].subfield.display_name | Sociology and Political Science |
| topics[0].display_name | COVID-19 Prevention and Impact |
| topics[1].id | https://openalex.org/T14463 |
| topics[1].field.id | https://openalex.org/fields/36 |
| topics[1].field.display_name | Health Professions |
| topics[1].score | 0.9616000056266785 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3600 |
| topics[1].subfield.display_name | General Health Professions |
| topics[1].display_name | Diverse Scientific Research Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8140684366226196 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C29456083 |
| concepts[1].level | 1 |
| concepts[1].score | 0.5263427495956421 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[1].display_name | Gynecology |
| concepts[2].id | https://openalex.org/C15708023 |
| concepts[2].level | 1 |
| concepts[2].score | 0.3361518383026123 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[2].display_name | Humanities |
| concepts[3].id | https://openalex.org/C142362112 |
| concepts[3].level | 0 |
| concepts[3].score | 0.026369065046310425 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q735 |
| concepts[3].display_name | Art |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8140684366226196 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/gynecology |
| keywords[1].score | 0.5263427495956421 |
| keywords[1].display_name | Gynecology |
| keywords[2].id | https://openalex.org/keywords/humanities |
| keywords[2].score | 0.3361518383026123 |
| keywords[2].display_name | Humanities |
| keywords[3].id | https://openalex.org/keywords/art |
| keywords[3].score | 0.026369065046310425 |
| keywords[3].display_name | Art |
| language | id |
| locations[0].id | doi:10.36418/syntax-literate.v9i12.55251 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210178106 |
| locations[0].source.issn | 2541-0849, 2548-1398 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2541-0849 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Syntax Literate Jurnal Ilmiah Indonesia |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Syntax Literate ; Jurnal Ilmiah Indonesia |
| locations[0].landing_page_url | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5115638773 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Kadek Agastya Widya Sedana Grudug |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kadek Agastya Widya Sedana Grudug |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5027666322 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3212-262X |
| authorships[1].author.display_name | I Made Jawi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | I Made Jawi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5000871166 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | I Gusti Ayu Artini |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | I Gusti Ayu Artini |
| authorships[2].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Penggunaan Obat Antivirus Bagi Penderita COVID – 19 di RS Universitas Udayana Tahun 2022 – 2023 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13032 |
| primary_topic.field.id | https://openalex.org/fields/33 |
| primary_topic.field.display_name | Social Sciences |
| primary_topic.score | 0.9833999872207642 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3312 |
| primary_topic.subfield.display_name | Sociology and Political Science |
| primary_topic.display_name | COVID-19 Prevention and Impact |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.36418/syntax-literate.v9i12.55251 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210178106 |
| best_oa_location.source.issn | 2541-0849, 2548-1398 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2541-0849 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Syntax Literate Jurnal Ilmiah Indonesia |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Syntax Literate ; Jurnal Ilmiah Indonesia |
| best_oa_location.landing_page_url | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| primary_location.id | doi:10.36418/syntax-literate.v9i12.55251 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210178106 |
| primary_location.source.issn | 2541-0849, 2548-1398 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2541-0849 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Syntax Literate Jurnal Ilmiah Indonesia |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Syntax Literate ; Jurnal Ilmiah Indonesia |
| primary_location.landing_page_url | https://doi.org/10.36418/syntax-literate.v9i12.55251 |
| publication_date | 2024-12-25 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.- | 91, 108 |
| abstract_inverted_index.19 | 51, 83, 104 |
| abstract_inverted_index.RS | 26, 53, 85, 111 |
| abstract_inverted_index.di | 9, 25, 52, 84, 110 |
| abstract_inverted_index.101 | 136, 180 |
| abstract_inverted_index.26. | 130 |
| abstract_inverted_index.IBM | 128 |
| abstract_inverted_index.dan | 12, 145, 160, 186 |
| abstract_inverted_index.ini | 40, 62 |
| abstract_inverted_index.– | 50, 59, 71, 82, 103, 119 |
| abstract_inverted_index.2022 | 58, 90, 107 |
| abstract_inverted_index.2023 | 60, 109 |
| abstract_inverted_index.Dari | 178 |
| abstract_inverted_index.Data | 93 |
| abstract_inverted_index.SPSS | 129 |
| abstract_inverted_index.awal | 18 |
| abstract_inverted_index.bagi | 79 |
| abstract_inverted_index.dari | 117, 134 |
| abstract_inverted_index.data | 124 |
| abstract_inverted_index.izin | 116 |
| abstract_inverted_index.kali | 7 |
| abstract_inverted_index.muda | 190 |
| abstract_inverted_index.obat | 23, 45, 77, 172, 220 |
| abstract_inverted_index.oleh | 3 |
| abstract_inverted_index.pada | 29, 47, 56, 88, 105 |
| abstract_inverted_index.usia | 147, 188 |
| abstract_inverted_index.yang | 1, 121, 151, 174, 198, 207, 223 |
| abstract_inverted_index.19-35 | 148, 195 |
| abstract_inverted_index.2020. | 19 |
| abstract_inverted_index.2023. | 92 |
| abstract_inverted_index.63,4% | 156 |
| abstract_inverted_index.COVID | 49, 81, 102 |
| abstract_inverted_index.Cina, | 11 |
| abstract_inverted_index.Hasil | 131 |
| abstract_inverted_index.baya, | 193 |
| abstract_inverted_index.besar | 203 |
| abstract_inverted_index.dalam | 168, 225 |
| abstract_inverted_index.lebih | 184 |
| abstract_inverted_index.medis | 100 |
| abstract_inverted_index.paruh | 192 |
| abstract_inverted_index.pihak | 118, 120 |
| abstract_inverted_index.rekam | 99 |
| abstract_inverted_index.sejak | 17 |
| abstract_inverted_index.tahun | 57, 89, 106, 149 |
| abstract_inverted_index.total | 135, 179 |
| abstract_inverted_index.untuk | 32, 42, 73 |
| abstract_inverted_index.utama | 222 |
| abstract_inverted_index.virus | 4 |
| abstract_inverted_index.(cross | 70 |
| abstract_inverted_index.50,5%, | 144 |
| abstract_inverted_index.Wuhan, | 10 |
| abstract_inverted_index.adalah | 140, 171, 197 |
| abstract_inverted_index.banyak | 153, 200 |
| abstract_inverted_index.dengan | 66, 97, 126, 142 |
| abstract_inverted_index.dewasa | 189 |
| abstract_inverted_index.diolah | 125 |
| abstract_inverted_index.global | 16 |
| abstract_inverted_index.hingga | 191 |
| abstract_inverted_index.paling | 152, 175, 199 |
| abstract_inverted_index.pasien | 101, 137, 157, 162, 181, 204, 213 |
| abstract_inverted_index.potong | 68 |
| abstract_inverted_index.rendah | 166 |
| abstract_inverted_index.secara | 95 |
| abstract_inverted_index.sering | 176 |
| abstract_inverted_index.tahun, | 196 |
| abstract_inverted_index.terapi | 37 |
| abstract_inverted_index.Udayana | 28, 55, 87, 113 |
| abstract_inverted_index.ancaman | 14 |
| abstract_inverted_index.derajat | 164, 215 |
| abstract_inverted_index.dominan | 185 |
| abstract_inverted_index.kondisi | 209 |
| abstract_inverted_index.lengkap | 35 |
| abstract_inverted_index.lintang | 69 |
| abstract_inverted_index.melihat | 98 |
| abstract_inverted_index.menjadi | 13 |
| abstract_inverted_index.mereka. | 210 |
| abstract_inverted_index.penting | 31 |
| abstract_inverted_index.pertama | 6 |
| abstract_inverted_index.rendah, | 217 |
| abstract_inverted_index.sekitar | 155 |
| abstract_inverted_index.setelah | 114 |
| abstract_inverted_index.tentang | 36 |
| abstract_inverted_index.terapi, | 226 |
| abstract_inverted_index.(73,3%); | 167 |
| abstract_inverted_index.Kemudian | 123 |
| abstract_inverted_index.Meskipun | 211 |
| abstract_inverted_index.Sebagian | 202 |
| abstract_inverted_index.gambaran | 34, 75 |
| abstract_inverted_index.kelompok | 146, 187 |
| abstract_inverted_index.memiliki | 158, 205 |
| abstract_inverted_index.mengenai | 21 |
| abstract_inverted_index.software | 127 |
| abstract_inverted_index.terutama | 194 |
| abstract_inverted_index.2022-2023 | 30 |
| abstract_inverted_index.COVID-19, | 0, 138, 182 |
| abstract_inverted_index.COVID-19. | 38 |
| abstract_inverted_index.antivirus | 24, 46, 78, 173, 221 |
| abstract_inverted_index.digunakan | 224 |
| abstract_inverted_index.dilakukan | 41 |
| abstract_inverted_index.ditemukan | 8 |
| abstract_inverted_index.keparahan | 165, 216 |
| abstract_inverted_index.kesehatan | 15 |
| abstract_inverted_index.komorbid, | 159, 206 |
| abstract_inverted_index.laki-laki | 141, 183 |
| abstract_inverted_index.mayoritas | 139, 161, 212 |
| abstract_inverted_index.mengalami | 163, 214 |
| abstract_inverted_index.merupakan | 63, 150, 219 |
| abstract_inverted_index.penderita | 48, 80 |
| abstract_inverted_index.terpapar; | 154 |
| abstract_inverted_index.Penelitian | 20, 39, 61 |
| abstract_inverted_index.deskriptif | 65 |
| abstract_inverted_index.digunakan. | 177 |
| abstract_inverted_index.disebabkan | 2 |
| abstract_inverted_index.memberikan | 33 |
| abstract_inverted_index.mengetahui | 43, 74 |
| abstract_inverted_index.menunjukan | 133 |
| abstract_inverted_index.pendekatan | 67 |
| abstract_inverted_index.penelitian | 64, 132 |
| abstract_inverted_index.penggunaan | 22, 44, 76 |
| abstract_inverted_index.persentase | 143 |
| abstract_inverted_index.sectional) | 72 |
| abstract_inverted_index.Favipiravir | 170, 218 |
| abstract_inverted_index.SARS-CoV-2, | 5 |
| abstract_inverted_index.Universitas | 27, 54, 86, 112 |
| abstract_inverted_index.dikumpulkan | 94 |
| abstract_inverted_index.memperburuk | 208 |
| abstract_inverted_index.mendapatkan | 115 |
| abstract_inverted_index.penanganan, | 169 |
| abstract_inverted_index.terinfeksi. | 201 |
| abstract_inverted_index.retrospektif | 96 |
| abstract_inverted_index.bersangkutan. | 122 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.43763429 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |